Explore 3 Stock Ideas & Industry Insights Download Free Report

Asahi Kaisei Corp

Industrials US AHKSY

21.87USD
-0.08(0.36%)

Last update at 2026-06-03T18:18:00Z

Day Range

21.8521.87
LowHigh

52 Week Range

12.4123.96
LowHigh

Fundamentals

  • Previous Close 21.95
  • Market Cap13076.09M
  • Volume140
  • P/E Ratio14.83
  • Dividend Yield2.78%
  • EBITDA418008.01M
  • Revenue TTM3039322.96M
  • Revenue Per Share TTM4475.68
  • Gross Profit TTM 987499.00M
  • Diluted EPS TTM1.30

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax 194602.00M 28843.00M -61906.00000M 215121.00M 150906.00M
Minority interest -5408.00000M -2522.00000M -1942.00000M -1954.00000M 27058.00M
Net income 134997.00M 43806.00M -91312.00000M 161880.00M 79768.00M
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit 958260.00M 815969.00M 773776.00M 769768.00M 680709.00M
Reconciled depreciation 186106.00M 182196.00M 176651.00M 148129.00M 133272.00M
Ebit 203698.00M 36291.00M 127443.00M 215695.00M 178627.00M
Ebitda 389804.00M 218487.00M 304094.00M 363824.00M 311899.00M
Depreciation and amortization 186106.00M 182196.00M 176651.00M 148129.00M 133272.00M
Non operating income net other - - - - -
Operating income 211921.00M 140746.00M 128352.00M 202647.00M 171808.00M
Other operating expenses 2825391.00M 2644132.00M 2598133.00M 2258671.00M 1934243.00M
Interest expense 9096.00M 7448.00M 5907.00M 3643.00M 3209.00M
Tax provision 54197.00M -17485.00000M 27464.00M 51287.00M 68808.00M
Interest income 9982.00M 7684.00M 3896.00M 1364.00M 1895.00M
Net interest income 886.00M 236.00M -2011.00000M -2279.00000M -1314.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 54197.00M -17485.00000M 27464.00M 51287.00M 68808.00M
Total revenue 3037312.00M 2784878.00M 2726485.00M 2461317.00M 2106051.00M
Total operating expenses 746340.00M 675223.00M 645424.00M 567122.00M 508901.00M
Cost of revenue 2079051.00M 1968909.00M 1952709.00M 1691549.00M 1425342.00M
Total other income expense net -17319.00000M -111903.00000M -190258.00000M 12475.00M -20902.00000M
Discontinued operations - - - - -
Net income from continuing ops 140405.00M 46328.00M -89370.00000M 163834.00M 82098.00M
Net income applicable to common shares - - - 161880.00M 79768.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 4015214.00M 3662730.00M 3454526.00M 3349075.00M 2918941.00M
Intangible assets 540913.00M 394052.00M 368695.00M 405508.00M 342453.00M
Earning assets - - - - -
Other current assets 165237.00M 150029.00M 151769.00M 114724.00M 94906.00M
Total liab 2101270.00M 1814105.00M 1758517.00M 1630259.00M 1424407.00M
Total stockholder equity 1859421.00M 1813391.00M 1660922.00M 1687411.00M 1467476.00M
Deferred long term liab - - - - -
Other current liab 434061.00M 384587.00M 110685.00M 110779.00M 88532.00M
Common stock 103389.00M 103389.00M 103389.00M 103389.00M 103389.00M
Capital stock 103389.00M 103389.00M 103389.00M 103389.00M 103389.00M
Retained earnings 1191076.00M 1135533.00M 1142325.00M 1282325.00M 1158792.00M
Other liab - - - 283910.00M 286919.00M
Good will 389640.00M 360676.00M 368089.00M 431335.00M 351921.00M
Other assets - - - 1.00M 1.00M
Cash 393467.00M 338108.00M 251181.00M 244641.00M 221779.00M
Cash and equivalents - - - - -
Total current liabilities 964608.00M 914572.00M 912163.00M 923850.00M 703163.00M
Current deferred revenue - 83034.00M 254120.00M 280264.00M 243093.00M
Net debt 801578.00M 617453.00M 723567.00M 532574.00M 441997.00M
Short term debt 318298.00M 298906.00M 366798.00M 354715.00M 229451.00M
Short long term debt 310249.00M 291091.00M 360032.00M 352491.00M 228571.00M
Short long term debt total 1195045.00M 955561.00M 974748.00M 777215.00M 663776.00M
Other stockholder equity 564956.00M 574469.00M -1245714.00000M -1385714.00000M -1262181.00000M
Property plant equipment - - - 805215.00M 717262.00M
Total current assets 1769448.00M 1650037.00M 1488195.00M 1334209.00M 1136776.00M
Long term investments - - - - -
Net tangible assets - - - 850567.00M 773101.00M
Short term investments - -93399.00000M -90853.00000M -65604.00000M 5544.00M
Net receivables 491414.00M 483064.00M 442692.00M 434595.00M 338640.00M
Long term debt 847209.00M 625926.00M 579424.00M 413785.00M 430404.00M
Inventory 719330.00M 678836.00M 642553.00M 540249.00M 481451.00M
Accounts payable 193583.00M 213252.00M 180560.00M 178092.00M 142087.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 501513.00M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 157014.00M 101755.00M 8466.00M 6226.00M 62895.00M
Deferred long term asset charges - - - - -
Non current assets total 2245766.00M 2012693.00M 1966331.00M 2014865.00M 1782164.00M
Capital lease obligations 37587.00M 38544.00M 35292.00M 10939.00M 4801.00M
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -381150.00000M -142598.00000M -213584.00000M 31589.00M 10274.00M
Change to liabilities - - - 31576.00M 1706.00M
Total cashflows from investing activities -381150.00000M -142598.00000M - -221019.00000M -157751.00000M
Net borrowings 222422.00M -33673.00000M - 94434.00M -48336.00000M
Total cash from financing activities 144567.00M -94331.00000M 111780.00M 42321.00M -95869.00000M
Change to operating activities - - - -13276.00000M 33005.00M
Net income 194602.00M 43806.00M -61906.00000M 215121.00M 150906.00M
Change in cash 56537.00M 85595.00M 4955.00M 26713.00M 11464.00M
Begin period cash flow 333498.00M 247903.00M 242948.00M 216235.00M 204771.00M
End period cash flow 390035.00M 333498.00M 247903.00M 242948.00M 216235.00M
Total cash from operating activities 301489.00M 295300.00M 90804.00M 183271.00M 253676.00M
Issuance of capital stock 122.00M 122.00M 208.00M 125.00M 69.00M
Depreciation 186106.00M 182196.00M 176651.00M 148129.00M 133272.00M
Other cashflows from investing activities -12115.00000M -28093.00000M - 52.00M -296.00000M
Dividends paid 49962.00M 49962.00M -48575.00000M -47187.00000M -45800.00000M
Change to inventory -32068.00000M -16303.00000M -84053.00000M -73257.00000M 6110.00M
Change to account receivables 2816.00M -19087.00000M 8405.00M -45911.00000M 5214.00M
Sale purchase of stock -30019.00000M -12.00000M -1415.00000M -412.00000M -10.00000M
Other cashflows from financing activities 2004.00M -10806.00000M 237023.00M 140889.00M -33192.00000M
Change to netincome - - - -79111.00000M -5399.00000M
Capital expenditures 217939.00M 171954.00M 172158.00M 169708.00M 150292.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -9794.00000M 998.00M -81107.00000M -81756.00000M 30139.00M
Stock based compensation - - - - -
Other non cash items -69425.00000M 68300.00M 57166.00M -98223.00000M -60641.00000M
Free cash flow 83550.00M 123346.00M -81354.00000M 13563.00M 103384.00M

Peer Comparison

Sector: Industrials Industry: Conglomerates

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AHKSY
Asahi Kaisei Corp
-0.08 0.36% 21.87 14.83 17.70 0.0043 1.05 0.93 7.07
HON
Honeywell International Inc
-11.97 5.09% 223.26 23.08 19.72 3.48 8.06 3.85 15.52
MMM
3M Company
-1.25 0.82% 151.65 14.69 17.76 2.45 16.54 2.55 9.07
MSBHF
Mitsubishi Corp.
0.45 1.47% 31.00 10.00 - 0.0032 1.08 0.0046 0.05
HTHIY
Hitachi Ltd ADR
0.63 1.96% 32.84 13.55 10.63 0.0062 1.66 0.0069 0.05

Reports Covered

Stock Research & News

Profile

Asahi Kasei Corporation engages in material, homes, healthcare businesses. The company offers Pimel photosensitive polyimide/PBO precursor, a liquid photosensitive material for buffer coating and packaging applications; Sunfort dry film photoresist to form circuit patterns on printed wiring boards; Novacure, a latent curing agent for epoxy resin with storage stability; glass fabric for printed circuit boards; plastic optical fiber; suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; Hipore, a microporous polyolefin sheet which prevents the anode and cathode from contacting one another; Celgard, a lithium-ion battery separator; Deramic, a lead acid battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, ROICA, ELTAS, Bemliese, EUTEC, Precisé, SEMIA, smash, PULSHUT, Lastan, Cubit, NanoAct, ECORISE, BioCradle, CMC-Bemliese names. It also provides cling film, bags and containers, and dishwashing liquid under the Saran Wrap, Ziploc, Cookper, Frosch names; packaging products under the OPS, Suntec, Barrialon, PVDC latex, and Saran names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company is involved in the provision of remodeling services; real estate-related operations; offers unit homes and apartment buildings; autoclaved aerated concrete, foundation systems, thermal insulation material, structural systems and components products; prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; enzymes and diagnostic products; and hemodialysis, therapeutic apheresis, and autologous blood-related businesses. The company was founded in 1931 and is headquartered in Tokyo, Japan.

Asahi Kaisei Corp

Hibiya Mitsui Tower, Tokyo, Japan, 100-0006

Key Executives

Name Title Year Born
Mr. Koshiro Kudo CFO, Presial Exec. Officer, Pres & Representative Director 1959
Mr. Toshiyasu Horie Sr. Exec. Officer, Exec. Officer for Strategy, Accounting & Fin., IR and Director 1962
Futoshi Hamamoto Gen. Mang. of Investor Relations NA
Hiroki Ideguchi Sr. Exec. Officer and Exec. Officer for Genl Affairs, Legal, Comm. Risk Mgmt. & Compliance, HR NA
Mr. Shuichi Sakamoto Primary Exec. Officer for Health Care Bus. Sector (joint) & Director 1957
Dr. Ichiro Oyama M.D. Chief Industrial Physician NA
Mr. Richard A. Packer Primary Exec. Officer & Exec. Officer for Health Care Bus. Sector (Joint) 1958
Mr. Kenji Hamai Primary Exec. Officer NA
Hideyuki Yamagishi Primary Exec. Officer NA
Mr. John W. Moyer Sr. Exec. Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions